Results - Announcements
Cipla Ltd share price slipped 0.22% to Rs 1350.0. The Company's net profit saw a mild growth of 8.82% to Rs 856.52 crore, while revenue from operations slightly gained 4.11% to Rs 7368.15 crore in Q3FY26 over Q2FY26.
The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.44 lakh crore, gaining 4.06%. It has marginally improved by 3.17% over last one week and eased lower by 0.26% in last one month while the market capitalization of Cipla Ltd has improved by 2.76% and 7.91% in the same period respectively.
Profit before tax (PBT) of Cipla Ltd stood at Rs 1177.34 crore in Q3 FY26, tumbling by 36.48% year-on-year, and rising 8.82% quarter-on-quarter. EBITDA came in at Rs 1237 crore, tanking 23.94% YoY and rallying 26.01% sequentially.
Total expenses grew marginally by 2.08% to Rs 6361.01 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 1523.74 crore, increasing 12.29% YoY, while employee benefits expense was at Rs 1474.61 crore, seeing a marginal contraction of 1.52% YoY.
For the TTM ended FY26, revenue from operations posted a slight growth of 2.09% to Rs 27711.69 crore, while net profit witnessed a sharp fall of 26.86% to Rs 3869.79 crore, compared to previous TTM. EBITDA surged by 636906% to Rs 5000.89 crore, and PBT tumbled by 23.42% to Rs 5223.63 crore compared to previous TTM.
The company's consolidated net cash flow from operating activities stood at Rs 3940.02 crore in FY26, as against Rs 5004.98 crore in FY25.
Cipla Ltd crashed 14.77% in last one year, significantly underperforming the benchmark BSE Sensex which has slipped by 13.19% during the same period.